MAP2K7 and thyroid gland carcinoma: In conclusion, our results demonstrate that EGCG could inhibit the growth and increase the apoptosis of human thyroid carcinoma cells via suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway.